Inventor · disambiguated record
I-Huang Lu
Also filed as: LU I-HUANG
4 granted patents·4 pending applications·0 citations·filing 2013–2023
55Inventor score
Files withIND TECH RES INST8
Top patents by PatentIndex Score
8 records- 0162US2024216454A1Method for treating dermatitis and pharmaceutical composition for treating dermatitis containing an adenostemma lavenia extractIND TECH RES INST·Filed 2023·Application pending·0 cites
- 0260US2022249395A1Pharmaceutical formulations for a liquid dosage form and a controlled release dosage formIND TECH RES INST·Filed 2022·Application pending·0 cites
- 0358US10821148B2Pharmaceutical composition for treating or alleviating an autoimmune disease and/or complication thereof and/or nephritis and method for treating or alleviating an autoimmune disease and/or complication thereof and/or nephritisIND TECH RES INST·Filed 2017·Granted Nov 3, 2020·0 cites·8 claims
- 0455US11400054B2Method for treating an autoimmune neurological disease and/or neurodegenerative disease and pharmaceutical formulations for a liquid dosage form and a controlled release dosage formIND TECH RES INST·Filed 2018·Granted Aug 2, 2022·0 cites·9 claims
- 0554US2021015882A1Pharmaceutical composition for treating or alleviating an autoimmune disease and/or complication thereof and/or nephritis and method for treating or alleviating an autoimmune disease and/or complication thereof and/or nephritisIND TECH RES INST·Filed 2020·Application pending·0 cites
- 0652US9682062B2Pharmaceutical compositions and method for inhibiting angiogenesisIND TECH RES INST·Filed 2013·Granted Jun 20, 2017·0 cites·2 claims
- 0749US9603882B2Method for modulating Th17 cells and method for treating a disease related to modulation of Th17 cellsIND TECH RES INST·Filed 2014·Granted Mar 28, 2017·0 cites·4 claims
- 0837US2016008319A1Pharmaceutical compositions for inhibiting angiogenesisIND TECH RES INST·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when I-Huang Lu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →